Industry

LAUSANNE, Switzerland–(BUSINESS WIRE)–MindMaze, a global pioneer in the development of neurotechnology, today confirms a new partnership with Alfa Romeo F1 Team ORLEN. Through this partnership, MindMaze will expand its groundbreaking research using its MindDrive brain technology platform to bring together advanced neuroscience, state-of-the-art technology, and engineering to boost safety and human performance in motorsport. “We … [Read more…]

#1 Cookie Brand in the Natural Channel Launches First Satiating, Planet-Forward Sandwich Cookie Made with Nut Flour and Nut Butter CHICAGO–(BUSINESS WIRE)–Simple Mills is re-defining the cookie aisle yet again with the launch of new Nut Butter Stuffed Sandwich Cookies, a delicious and nutritious snack that marries the nostalgic sandwich cookie you know and love … [Read more…]

The combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Through … [Read more…]

– Exelixis intends to discuss the results with the U.S. FDA to determine next steps toward a potential regulatory submission – – Trial to continue until the next analysis of the secondary endpoint of overall survival – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that COSMIC-313 met its primary endpoint, demonstrating significant improvement in … [Read more…]

REDWOOD CITY, Calif.–(BUSINESS WIRE)–#COVID19—Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced the appointment of Frank Glavin as Chief Executive Officer, bringing more than 20 years of biotech and pharma experience across the biotech value chain from early-stage research through to commercial planning and business development. Martin Moore, … [Read more…]

22nd consecutive year that Cotiviti’s solution has passed rigorous NCQA review process SALT LAKE CITY–(BUSINESS WIRE)–Quality Engine, the administrative measure logic and systematic sample processing component of Cotiviti’s Quality Intelligence solution, has earned Certified Measures status for the Healthcare Effectiveness Data and Information Set (HEDIS®) 2022 Measurement Year (MY 2022) from the National Committee for … [Read more…]

CHICAGO–(BUSINESS WIRE)–Thoughtworks (NASDAQ: TWKS), a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced the signing of a multi-year agreement with PCI Pharma Services, a leading global contract development and manufacturing organization (CDMO). Thoughtworks will help PCI in its journey to digitize its supply chain, with the goal of … [Read more…]

NATICK, Mass.–(BUSINESS WIRE)–Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of experienced biotechnology executive, Dawn Mattoon, PhD, as Chief Operating Officer, effective today. In her nearly 20-year career, Dr. Mattoon has developed and commercialized a broad range of innovative proteomic and genomic technologies. … [Read more…]

New and recent director nominees include industry trailblazers BJ Jones, Christine Lemke, Ken Ehlert and Chamath Palihapitiya BOSTON–(BUSINESS WIRE)–Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced the nominees for its future board of directors, effective upon the closing of Akili’s business combination with Social … [Read more…]

Further analysis of Phase III COMFORT™ data show Piclidenoson’s superior safety profile and higher patient compliance compared to Otezla® PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today that it is planning to … [Read more…]